Story
MIT Technology Review [ai] · Artificial Intelligence
← Back to your feed

Closing the data loop in AI-driven drug discovery

Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…

Read at MIT Technology Review [ai]

Join the conversation

Discuss the story with the TraceFeed community.

No comments yet. Be the first to add a perspective.

Make it part of your feed.

Sign up or log in to continue.